Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
Cantor Fitzgerald Initiates Coverage On Apellis Pharmaceuticals With Overweight Rating, Announces Price Target of $44
HC Wainwright & Co. Maintains Buy on Caribou Biosciences, Lowers Price Target to $3
Caribou Biosciences Analyst Ratings
Editas Medicine Analyst Ratings
Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms
Caribou to Prioritize Lead Cancer Programs in Portfolio Shakeup